-
ICD-10-CM Codes
›
-
G00-G99
Diseases of the nervous system
›
-
G10-G14
Systemic atrophies primarily affecting the central nervous system
›
-
G13-
Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
›
2018 ICD-10-CM Diagnosis Code G13
Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
2016 2017 2018 Non-Billable/Non-Specific Code
- G13 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- Short description: Systemic atrophies aff cnsl in diseases classd elswhr
- The 2018 edition of ICD-10-CM G13 became effective on October 1, 2017.
- This is the American ICD-10-CM version of G13 - other international versions of ICD-10 G13 may differ.
The following code(s) above
G13 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
G13:
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
ICD-10-CM Codes Adjacent To G13
G12.2 Motor neuron disease
G12.21 Amyotrophic lateral sclerosis
G12.22 Progressive bulbar palsy
G12.23 Primary lateral sclerosis
G12.24 Familial motor neuron disease
G12.25 Progressive spinal muscle atrophy
G12.29 Other motor neuron disease
G12.8 Other spinal muscular atrophies and related syndromes
G12.9 Spinal muscular atrophy, unspecified
G13
Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
G13.0 Paraneoplastic neuromyopathy and neuropathy
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease
G13.2 Systemic atrophy primarily affecting the central nervous system in myxedema
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere
G21 Secondary parkinsonism
G21.0 Malignant neuroleptic syndrome
G21.1 Other drug-induced secondary parkinsonism
G21.11 Neuroleptic induced parkinsonism
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
